It should be noticed that lack of IgG and/or IgM aCL and aβ2GP1 precludes the possible role of anti-phospholipid antibodies in CAC, and furthermore, the analyzed patients had a history of cardiovascular disease episodes, which increased itself the risk of subsequent thrombosis events. This evidence concerns the gene CD40LG and cardiovascular disorder.